Acute Abdominal Aortic Aneurysms: Cost Analysis of Endovascular Repair and Open Surgery in Hemodynamically Stable Patients with 1-year Follow-up

2008 ◽  
Vol 2008 ◽  
pp. 155-156
Author(s):  
G.L. Moneta
Radiology ◽  
2006 ◽  
Vol 240 (3) ◽  
pp. 681-689 ◽  
Author(s):  
Jacob J. Visser ◽  
Marc R. H. M. van Sambeek ◽  
M. G. Myriam Hunink ◽  
W. Ken Redekop ◽  
Lukas C. van Dijk ◽  
...  

2006 ◽  
Vol 44 (6) ◽  
pp. 1148-1155 ◽  
Author(s):  
Jacob J. Visser ◽  
Johanna L. Bosch ◽  
M.G. Myriam Hunink ◽  
Lukas C. van Dijk ◽  
Johanna M. Hendriks ◽  
...  

Vascular ◽  
2004 ◽  
Vol 12 (5) ◽  
pp. 312-317
Author(s):  
Maurizio Taurino ◽  
Vincenzo Visco ◽  
Salvatore Raffa ◽  
Benedetto Ricci ◽  
Massimo Ruggiero ◽  
...  

The objective of this prospective study was to assess matrix metalloproteinase 9 (MMP-9) activity in patients undergoing open surgery or endovascular repair of abdominal aortic aneurysms (AAAs), comparing changes in plasma levels in the two groups. We studied 12 patients after conventional open surgery and 9 patients after endovascular aneurysm repair. MMP-9 was assayed in plasma at baseline and 1 week and 1 month thereafter. Preoperative MMP-9 levels were similar in the two groups (41.7 ± 19.1 vs 44.4 ± 24.6 ng/mL; p = not significant). Assessment 1 week later showed that MMP levels in both repair groups had increased. In the open surgery group, they increased significantly (59.7 ± 16.8 ng/mL; p < .05) but not in the endovascular group (49.3 ± 32.4 ng/mL). One month later, MMP-9 levels decreased in both groups but not significantly (to 32.6 ± 24.6 ng/mL for open surgery repair and to 34.7 ± 23.5 ng/mL for endovascular repair). At 1 month after repair, MMP-9 levels decreased significantly only in smokers, whereas in nonsmokers, they did not (from 46.9 ± 22.1 to 31.7 ± 21.5 ng/mL in smokers [ p < .05] vs from 34.7 ± 17.4 to 37.1 ± 28.9 ng/mL in nonsmokers). This study confirms that enzyme secretion changes during the postoperative course. The differing patterns of MMP-9 expression prevent us from reaching definitive conclusions about the use of MMP-9 as a marker during early postprocedural follow-up. An important matter to clarify is the role of MMP-9 in long-term follow-up, especially after endovascular AAA repairs.


2016 ◽  
Vol 117 ◽  
pp. S17-S18
Author(s):  
Emre Gök ◽  
Mehmet Akif Onalan ◽  
Metin Onur Beyaz ◽  
Celalettin Karatepe ◽  
Bayer Cinar ◽  
...  

2014 ◽  
Vol 60 (6) ◽  
pp. 1439-1445 ◽  
Author(s):  
Prateek K. Gupta ◽  
Bala Ramanan ◽  
Travis L. Engelbert ◽  
Girma Tefera ◽  
John R. Hoch ◽  
...  

2020 ◽  
Vol 71 (2) ◽  
pp. 432-443.e4 ◽  
Author(s):  
Akshay Kumar Gupta ◽  
Husain N. Alshaikh ◽  
Hanaa Dakour-Aridi ◽  
Ryan W. King ◽  
Thomas E. Brothers ◽  
...  

2019 ◽  
Vol 56 (5) ◽  
pp. 993-1000 ◽  
Author(s):  
Enrico Gallitto ◽  
Gianluca Faggioli ◽  
Rodolfo Pini ◽  
Chiara Mascoli ◽  
Stefano Ancetti ◽  
...  

Abstract OBJECTIVES Our objective was to report the outcomes of fenestrated/branched endovascular aneurysm repair of thoraco-abdominal aortic aneurysms (TAAAs) with endografts. METHODS Between January 2010 and April 2018, patients with TAAAs, considered at high surgical risk for open surgery and treated by Cook-Zenith fenestrated/branched endovascular aneurysm repair, were prospectively enrolled and retrospectively analysed. The early end points were 30-day/hospital mortality rate, spinal cord ischaemia and 30-day cardiopulmonary and nephrological morbidity. Follow-up end points were survival, patency of target visceral vessels and freedom from reinterventions. RESULTS Eighty-eight patients (male: 77%; mean age: 73 ± 7 years; American Society of Anesthesiologists 3/4: 58/42%) were enrolled. Using Crawford’s classification, 43 (49%) were types I–III and 45 (51%) were type IV TAAAs. The mean aneurysm diameter was 65 ± 15 mm. Custom-made and off-the-shelf endografts were used in 60 (68%) and 28 (32%) cases, respectively. Five (6%) patients had a contained ruptured TAAA. The procedure was performed in multiple steps in 42 (48%) cases. There was 1 (1%) intraoperative death. Five (6%) patients suffered spinal cord ischaemia with permanent paraplegia in 3 (3%) cases. Postoperative cardiac and pulmonary complications occurred in 7 (8%) and 12 (14%) patients, respectively. Worsening of renal function (≥30% of baseline level) was detected in 11 (13%) cases, and 2 (2%) patients required haemodialysis. The 30-day and hospital mortality rates were 5% and 8%, respectively. The mean follow-up was 36 ± 22 months. Survival at 12, 24 and 36 months was 89%, 75% and 70%, respectively. The patency of target visceral vessels at 12, 24 and 36 months was 92%, 92% and 92%, respectively. Freedom from reinterventions at 12, 24 and 36 months was 85%, 85% and 83%, respectively. CONCLUSIONS The endovascular repair of TAAAs with fenestrated/branched endovascular aneurysm repair is feasible and effective with acceptable technical/clinical outcomes at early/midterm follow-up.


Sign in / Sign up

Export Citation Format

Share Document